Select Page

NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Legend Biotech Corporation (NASDAQ: LEGN) resulting from allegations that Legend may have issued materially misleading business information to the investing public.